Molecules/TOSITUMOMAB

TOSITUMOMAB

Molecular Identity

AntibodyApprovedFirst approved 2003

Mechanism of action: B-lymphocyte antigen CD20 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

TOSITUMOMABTOSITUMOMAB COMPONENT OF BEXXAR

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to TOSITUMOMAB

Loading drug network...